• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) Back to Search Results
Model Number G124
Device Problems Failure to Capture (1081); Over-Sensing (1438); Pacing Problem (1439); Connection Problem (2900)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/03/2023
Event Type  Injury  
Event Description
It was reported that an alert was received through latitude due to right ventricular (rv) automatic threshold detected as greater than programmed amplitude or suspended.Upon further review, it was discussed that there is left ventricular (lv) oversensing, which results in inhibition of biventricular pacing.The patient is not pacemaker dependent.It was also mentioned that the alert received is due to fusion and intrinsic beat events, which is likely a result of the abnormal sensed events in the lv.Further in-clinic assessment was recommended as there is the possibility that the right atrial (ra) and lv leads are reversed in the device header, or the ra and lv leads position could be suboptimal.Troubleshooting suggestions were provided.In addition, the presenting electrogram (egm) continues to show atrio-ventricular dyssynchrony and there is no atrial capture.In-clinic testing was performed and the lead tests confirmed the atrial and left ventricular leads are likely reversed in the header.As a result, the device has been reprogrammed for the time being and the lead revision procedure has been scheduled.Lead revision was performed as scheduled and the lv and ra leads were adequately connected to the device header.The lead tests are showing appropriate measurements and the sensitivity was adjusted.The cardiac resynchronization therapy defibrillator (crt-d) system remains in service.No additional adverse patient effects were reported.
 
Event Description
It was reported that an alert was received through latitude due to right ventricular (rv) automatic threshold detected as greater than programmed amplitude or suspended.Upon further review, it was discussed that there is left ventricular (lv) oversensing, which results in inhibition of biventricular pacing.The patient is not pacemaker dependent.It was also mentioned that the alert received is due to fusion and intrinsic beat events, which is likely a result of the abnormal sensed events in the lv.Further in-clinic assessment was recommended as there is the possibility that the right atrial (ra) and lv leads are reversed in the device header, or the ra and lv leads position could be suboptimal.Troubleshooting suggestions were provided.In addition, the presenting electrogram (egm) continues to show atrio-ventricular dyssynchrony and there is no atrial capture.In-clinic testing was performed and the lead tests confirmed the atrial and left ventricular leads are likely reversed in the header.As a result, the device has been reprogrammed for the time being and the lead revision procedure has been scheduled.Lead revision was performed as scheduled and the lv and ra leads were adequately connected to the device header.The lead tests are showing appropriate measurements and the sensitivity was adjusted.The cardiac resynchronization therapy defibrillator (crt-d) system remains in service.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOMENTUM CRT-D
Type of Device
CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key16196678
MDR Text Key307613147
Report Number2124215-2023-01888
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 01/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/08/2024
Device Model NumberG124
Device Catalogue NumberG124
Device Lot Number508380
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/12/2023
Initial Date FDA Received01/18/2023
Supplement Dates Manufacturer Received01/31/2023
Supplement Dates FDA Received01/31/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/14/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age58 YR
-
-